Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Synthetic Genomics

Founders David C. Kiernan Hamilton Smith J. Venter Juan Enriquez



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Rounds per year 0.06
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Health Diagnostics
  • Genetics

Synthetic Genomics appeared to be the Corporate Investor, which was created in 2005. The main office of represented Corporate Investor is situated in the La Jolla. The venture was found in North America in United States.

The important activity for fund was in 2014. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Human Longevity. Among the most successful fund investment fields, there are Health Care, Genetics.

The current fund was established by David C. Kiernan, Hamilton Smith, J. Venter, Juan Enriquez.

The typical case for the fund is to invest in rounds with 7 participants. Despite the Synthetic Genomics, startups are often financed by Singularity University Ventures. The meaningful sponsors for the fund in investment in the same round are Threshold, Tan Thay, OS Fund. In the next rounds fund is usually obtained by Threshold, StartUp Health, OS Fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Synthetic Genomics:
Typical Co-investors
Synthetic Genomics is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Synthetic Genomics:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AirFinance Ventures -
Colfax Creek Birmingham, Michigan, United States
D. E. Shaw & Co. New York, New York, United States
GP Investments Bermuda, Hamilton
GXS Foundation China, Hangzhou, Zhejiang
Inter-Asia Venture Management China, Hong Kong, Hong Kong Island
KKBOX Group -
LNB group India, Kolkata, West Bengal
Loeb Partners Corporation New York, New York, United States
MadDog Ventures Birmingham, Michigan, United States
Meruelo Capital Partners California, Downey, United States
Ocean Energy -
Option3Ventures New York, New York, United States
Phyto Partners Boca Raton, Florida, United States
Relia Japan, Kanagawa Prefecture, Kawasaki
Shinyway Education China, Hangzhou, Zhejiang
Synergetic Innovation Fund Management China, Hunan, Nanshan
The Growth Fund Australia, New South Wales, Sydney
VenCraft California, San Mateo, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Human Longevity

Health Care
Health Diagnostics
$80M04 Mar 2014 San Diego, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Synthetic Genomics?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 80M
Rounds per year 0.06
Peak activity year 2014
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Human Longevity

Health Care
Health Diagnostics
$80M04 Mar 2014 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: